{"ticker": {"uuid": "5f9a4f24-7991-4b59-b199-1c6ef8a5b9ba", "symbol": "NSB", "name": "NeuroScientific Biopharmaceuticals Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Neuroscientific Biopharmaceuticals (ASX:NSB) Surges as Neurological Drug Research Returns to Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOZWRxV3ZCRlZIa21ob1FpeThpemVpSTlWQWNobXpJNmJnQV9ldFFSak5MM2psanRkUEIwd2ZYRGczN19sY1lfOUdtbTJndVRqZkphbG52a2RTZ3psSGgxTThQczJuaTY1U3kwZ3RrMm9xcUNseWxDVnN6d3Zxb25EQUZaa2lDZU01QUJsYzNKWldqS2lBampqNHlKNE4wWmQ1Uy03NGlsVWYtUWZEWS12RmRlR29Sek1xOXctWjlwUEZUbTJWZkdEVHFId0NNWWM?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:17:00+00:00", "published_display": "13 Jul 2026 08:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why NeuroScientific Biopharmaceuticals (ASX:NSB) Shares are Trading Higher on Tuesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNTBTa092WUtUSHNKSjJEajV4NTN4VGZkM2N2WXFSUUxjU2UzcDFNWmNfcU9hVnZna3hzRTY0eHpUWVJkb09JMGxjWFl5andRYXFvaUNPQUdhSGl5c0Z5Y0REbTFNQzJGWnpIX3JOYko5WC1CazRZRDFHYVhsMlExUGtFQU5pbHVmTldKSG53eTBrZ1VmR1VPQWpQblkyN2FzWUxzaUd1M3cta1JVd291TE56OW5NaFJNZEJKeEJB?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daily Special: ClearVue Technologies, NeuroScientific Biopharmaceuticals, Lithium Energy", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPc1FxS0pqM1pjcmI4TnkzeFpyR2hhNUYtcWZzY3dNbjZORGVla2lFcHdWLXFJMmlHSFliS1BfZXlWaUZVaWNRUUxBYjNsbURzRUxncUxHcEYtclNBOE9jZUdRSnRuQjd6Q0xsa1A3LVFBcHFVOHdWNnJRU180M0NDcw?oc=5", "source_name": "Finance News Network", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific advances StemSmart therapy with fourth patient treated in Crohn\u2019s disease program", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPbEFEX2RTU3hMa2otR25RUjNFRXFZcXVXUlIxbkNJc0xjcDhlbUM3UmJfdzVWWUJ2d09QTFBWejVRRGVnY0tINXVTdVAzNU9QV25YS1ZxSFNOTHpMTUdYVGJ3SlM1Xzh0X3A2WkNXd3FncGxfTHU3MU53QWhDNWFKZ0E5NTZ5d0ZjZkRJSmQwOHFpeElpUkxZbnVyMUtfMVhNdGwwZUduUFNTVlFrNHFoXzYxQ3Nzd2ZNN2JrVjVucUF3M3ZsZDRscVBrMTM?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: NeuroScientific Biopharmaceuticals Ltd (ASX:NSB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBUcFhXWEFRTnNGRHY4WWVpTWctdnBjRE5lV2ZzbEZCUnVfYTZBWUdFdV85dF9pbk5QSmM3YVJwckY0OUk5WFJfNDUweHc0YUJO?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T20:30:03+00:00", "published_display": "30 Oct 2025 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuroscientific Biopharmaceuticals Ltd (NSB) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE9lY1lRall0SXIwdlg4alBwaXZjcFNHYWlSX3ltR3FsRlBNak0tc1NfYmxQV012ejVNeEVJZ09HdjZQSEVTc1JyUWs0ZUVkM20xYVpKY3NLbGY?oc=5", "source_name": "Moomoo", "published_at": "2025-09-19T22:46:19+00:00", "published_display": "19 Sep 2025 22:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) 117% Price Boost Is Out Of Tune With Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxNS0JkX1ozdUdHNTJzUlRldjZ5VE55U05PbTBnellBY2FIR1RxOUpKUU8tVVB2SkJBbGVZYURBTjF5RkUwV1BKY2xsYVRhcTRQYkFTQ1BVXzlBeDBpSUxRdkM5UUd0VzFKWEE4RVRBQkMwc09iR0kza0FzQUpxTFJtZXNON2xwdWtMaVZsMlhoVVRMTk5GRnl2RVl6SzlpRGVSR3JTVG9BZlNiX3NrQUV3cUJpX3JYbHJlNHRTb3NEREgtWVJ0VG9KRTBJSVVqNGNHdmhwQnVrU2JXY282LU5HeFcyNjNkcGFSeXh3cXhlalRjQWZjOG8yZ2FLTVpqbFJC0gGGAkFVX3lxTFBzazhHdW8zcHdpcklfdnFEUTJ4X3RFX1pIaW5TaDV1OWU0RDZVOXk0WjJVbUpZSkE4Y3hrSk1GeUUwYk1sQ3M4aDBIVF8wSTlmT21YVjhwQjUtcWFqM2dfV0tnRkpPdVFLcXF2UXd1S0Y2SVdFTldDd3ItcFI4OVRxeEVGTmExZllBVGQ0ODQwN0R0djJiY203bkhBUHotMFRPOEc2UUVhdDZYdG53aDZldTl6NWZyaUVTZ2t6U0VsMm5ybHhvcmx0dWZVZnRZV0hncFR4ejIxdG9EU2x1NGpaNmsyQTZDaTJYMDVRWk9SNE1Xa1lXalRiT0RKNkdrM1JxUFdaQ3c?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals acquires Isopogen to advance stem cell therapy for neurodegenerative disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNb0o5bU9WVVRtLVVRUTNOazdvaENmdDhzM0NpNGo3ekVJOXM1SXo5Q2ppR2pnWkNFN0Z3blhySk1HNzcya3BRTEFLVWdvQ1U0RlRQcnVwaG5hZWlyWWtpcDlkWjhPRUpuZWlNNzlScDlweldjdWdXbGZCQXpXVnVRVHRLdGpDbWttMUwyd2VFbENoX1U3c1E2aFlkaTlmd2d0ajFvZGhPOA?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-04-16T07:00:00+00:00", "published_display": "16 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQekxDbHlrNWtLdDgwUTYwV3A4Q2FscGdPMTBwVmZFeHQ1RG1Yd05oNzRLSDJuQ2Q5QXVJaDZ0LWZtcjBXU1cwd0xjcEswVXV0eFljRlBObklJeEZocHc1Qm9oT0R0Y3dNd3V0X0RXSENCZkdFZWtienNjMnBQUm5rLWotdkhSbFd1Z3J4dXJtUzRTcW1xeURyUUExck9PODlXYVlldk9Tcw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T07:26:12+00:00", "published_display": "05 Feb 2020 07:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Neuroscientific Biopharmaceuticals (ASX:NSB) Surges as Neurological Drug Research Returns to Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOZWRxV3ZCRlZIa21ob1FpeThpemVpSTlWQWNobXpJNmJnQV9ldFFSak5MM2psanRkUEIwd2ZYRGczN19sY1lfOUdtbTJndVRqZkphbG52a2RTZ3psSGgxTThQczJuaTY1U3kwZ3RrMm9xcUNseWxDVnN6d3Zxb25EQUZaa2lDZU01QUJsYzNKWldqS2lBampqNHlKNE4wWmQ1Uy03NGlsVWYtUWZEWS12RmRlR29Sek1xOXctWjlwUEZUbTJWZkdEVHFId0NNWWM?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:17:00+00:00", "published_display": "13 Jul 2026 08:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why NeuroScientific Biopharmaceuticals (ASX:NSB) Shares are Trading Higher on Tuesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNTBTa092WUtUSHNKSjJEajV4NTN4VGZkM2N2WXFSUUxjU2UzcDFNWmNfcU9hVnZna3hzRTY0eHpUWVJkb09JMGxjWFl5andRYXFvaUNPQUdhSGl5c0Z5Y0REbTFNQzJGWnpIX3JOYko5WC1CazRZRDFHYVhsMlExUGtFQU5pbHVmTldKSG53eTBrZ1VmR1VPQWpQblkyN2FzWUxzaUd1M3cta1JVd291TE56OW5NaFJNZEJKeEJB?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daily Special: ClearVue Technologies, NeuroScientific Biopharmaceuticals, Lithium Energy", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPc1FxS0pqM1pjcmI4TnkzeFpyR2hhNUYtcWZzY3dNbjZORGVla2lFcHdWLXFJMmlHSFliS1BfZXlWaUZVaWNRUUxBYjNsbURzRUxncUxHcEYtclNBOE9jZUdRSnRuQjd6Q0xsa1A3LVFBcHFVOHdWNnJRU180M0NDcw?oc=5", "source_name": "Finance News Network", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific advances StemSmart therapy with fourth patient treated in Crohn\u2019s disease program", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPbEFEX2RTU3hMa2otR25RUjNFRXFZcXVXUlIxbkNJc0xjcDhlbUM3UmJfdzVWWUJ2d09QTFBWejVRRGVnY0tINXVTdVAzNU9QV25YS1ZxSFNOTHpMTUdYVGJ3SlM1Xzh0X3A2WkNXd3FncGxfTHU3MU53QWhDNWFKZ0E5NTZ5d0ZjZkRJSmQwOHFpeElpUkxZbnVyMUtfMVhNdGwwZUduUFNTVlFrNHFoXzYxQ3Nzd2ZNN2JrVjVucUF3M3ZsZDRscVBrMTM?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: NeuroScientific Biopharmaceuticals Ltd (ASX:NSB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBUcFhXWEFRTnNGRHY4WWVpTWctdnBjRE5lV2ZzbEZCUnVfYTZBWUdFdV85dF9pbk5QSmM3YVJwckY0OUk5WFJfNDUweHc0YUJO?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T20:30:03+00:00", "published_display": "30 Oct 2025 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuroscientific Biopharmaceuticals Ltd (NSB) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE9lY1lRall0SXIwdlg4alBwaXZjcFNHYWlSX3ltR3FsRlBNak0tc1NfYmxQV012ejVNeEVJZ09HdjZQSEVTc1JyUWs0ZUVkM20xYVpKY3NLbGY?oc=5", "source_name": "Moomoo", "published_at": "2025-09-19T22:46:19+00:00", "published_display": "19 Sep 2025 22:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) 117% Price Boost Is Out Of Tune With Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals acquires Isopogen to advance stem cell therapy for neurodegenerative disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNb0o5bU9WVVRtLVVRUTNOazdvaENmdDhzM0NpNGo3ekVJOXM1SXo5Q2ppR2pnWkNFN0Z3blhySk1HNzcya3BRTEFLVWdvQ1U0RlRQcnVwaG5hZWlyWWtpcDlkWjhPRUpuZWlNNzlScDlweldjdWdXbGZCQXpXVnVRVHRLdGpDbWttMUwyd2VFbENoX1U3c1E2aFlkaTlmd2d0ajFvZGhPOA?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-04-16T07:00:00+00:00", "published_display": "16 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQekxDbHlrNWtLdDgwUTYwV3A4Q2FscGdPMTBwVmZFeHQ1RG1Yd05oNzRLSDJuQ2Q5QXVJaDZ0LWZtcjBXU1cwd0xjcEswVXV0eFljRlBObklJeEZocHc1Qm9oT0R0Y3dNd3V0X0RXSENCZkdFZWtienNjMnBQUm5rLWotdkhSbFd1Z3J4dXJtUzRTcW1xeURyUUExck9PODlXYVlldk9Tcw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T07:26:12+00:00", "published_display": "05 Feb 2020 07:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 74, "total_relevant": 9, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 7, "score": 55, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.07, "latest_week": "2026-07-10", "one_week_move": 1.6, "four_week_move": -5.8, "twelve_week_move": -43.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.045775, "market_dynamics_buy_signal": false, "relative_strength": -48.241454, "fair_value_gap": -15.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 33.7565, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.6% over one week, -5.8% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 2}, {"label": "smallcaps.com.au", "count": 2}, {"label": "Finance News Network", "count": 1}, {"label": "BiotechDispatch", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "intelligentinvestor.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.6% over one week, -5.8% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Neuroscientific Biopharmaceuticals (ASX:NSB) Surges as Neurological Drug Research Returns to Focus"}], "updated_at": "2026-07-17T11:22:35.089062+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}